Abstract
In this issue of Blood, Yeomans et al identify MYC as an important target for translational regulation in chronic lymphocytic leukemia (CLL) cells after B-cell receptor (BCR) stimulation and show that current therapies suppress this induction.
MeSH terms
-
Gene Expression Regulation, Leukemic*
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
-
Proto-Oncogene Proteins c-myc / genetics*
-
RNA, Messenger / genetics*
-
Receptors, Antigen, B-Cell / immunology*
Substances
-
Proto-Oncogene Proteins c-myc
-
RNA, Messenger
-
Receptors, Antigen, B-Cell